Principal of Responsible Business Business Values and Ethics

Question: Describe about the Principal of Responsible Business for Business Values and Ethics. Answer: 1. From the above case study, it is required to bring out the main issues of ADSY. ADSY is pharmaceutical industry in Egypt (Lehoux et al., 2014). This particular company faces issues with low market share as it fails in competing with other multinationals in and around the world. Salem, sales and marketing Director of ADSY was little bit puzzled with the problem and called for immediate meeting for solving the problem. Rationale for the study is to analyze the fact regarding the sale of vaccines to physicians. Gentile (2015) argues that ADSY should offers incentive like other multinationals for retaining in the global marketplace. On the contrary, ADSY faces issues and needs counter argument by the sales team for gathering facts on low market share. In order to compete with multinationals, ADSY requires in finding innovative way and creating Unique Selling Proportion in the upcoming financial year. This case study on ADSY brings out real issues after viewing at the sales report for the year 2006. This needs to be addressed by the management of ADSY for sustaining in the near future (Gentile, 2013). 2. From the case study, stake for the key parties are the managing director of ADSY. Their money is invested at ADSY and loss in market share will affect their reputation largely. Edwards et al., (2012) suggest that sales team argued regarding low market share but kept point in finding innovative way in solving the issue. From the wording of Adel who is the top sales representatives of ADSY, he was of the opinion in offering incentives to the physicians like other multinationals (Edwards et al., 2014). ADSY is the distributors for top multinationals who aims at selling vaccines to physicians in and around the country. On the contrary, Chappell et al., (2013) suggest that ADSY discovers the problems faced by sales representatives for low market share. ADSY was under huge pressure for offering physical incentives. For the company ADSY, incentives system is mostly utilized by the top-multinationals at affordable prices (Arce Gentile, 2015). 3. Gentile (2015) argues that losing market share is a serious issue faced by ADSY. There are many opinions given by the members at team meeting for bringing improvement at ADSY. They have analyzed that physicians shows interest selling vaccines from multinationals as they renders incentive packages (Edwards et al., 2014). This kind of incentives involves commissions as well as gifts and free leisure trips. Some team members are of the opinion that providing invectives will degrade their present position and should concentrate any other concrete way of solving the issue as far as possible (Arce Gentile, 2015). Gentile (2015) argues that sale of pharmaceutical industry are mostly highly dependent especially for the prescription for drugs by the physicians to patients. Most of the top-multinationals are due to exertion of maximum effort for convincing physicians (Edwards et al., 2014). It involves prescribing products to patients. Addition to that, it should give incentives like drug samples as well as invitations to most of the international conferences (Lehoux et al., 2014). 4. According to Gentile (2015), this case study argues with persuasive response regarding issues with unethical behavior for the physicians. There arises ethical conflict between the physicians as well as patient welfare for taking into consideration for future analysis purpose. ADSY should plan ways for base their decisions depending upon the patients needs. ADSY aims at competing with other multinationals and gain high market share in the upcoming financial year. Problems arise as physicians mostly suggest expensive brands vaccines to the patients to get the extra margin of profits (Edwards et al., 2014). This has affected the market of ADSY largely and needs immediate attention by the sales team and directors of ADSY. Ethical dilemma faced by ADSY should be checked that led in losing market share in the current world (Arce Gentile, 2015). Edward et al., (2012) argues in maintaining leadership activities especially for producing as well as marketing of biological products and vaccines in the region. It should pace with recent technological progress as well as global competition at the same time. It requires contribution of satisfying the needs of the patients at affordable prices in and around the world (Lehoux et al., 2014). It is therefore important to consider the case study regarding the future impact of low market share for retaining in the global marketplace. Sales team and other representatives should make innovative plans for solving the issues. Reference List Arce, D. G., Gentile, M. C. (2015). Giving Voice to Values as a leverage point in business ethics education. Journal of Business Ethics, 131(3), 535-542. Chappell, S., Edwards, M. G., Webb, D. (2013). Sustaining Voices: Applying Giving Voice to Values to Sustainability Issues. Journal of Business Ethics Education, 10, 211-230. Edwards, M. G., Kirkham, N. (2014). Situating Giving Voice to Values: A metatheoretical evaluation of a new approach to business ethics. Journal of Business Ethics, 121(3), 477-495. Edwards, M. G., Webb, D., Chappell, S., Gentile, M. (2012). Giving Voice to Values: A new perspective on ethics in globalised organisational environments. Ethical models and applications of globalization: Culture, socio-political and economic perspectives, 160-185. Gentile, M. C. (2013). Giving voice to values. In Encyclopedia of Corporate Social Responsibility (pp. 1218-1221). Springer Berlin Heidelberg. Gentile, M. C. (2015). Learning about ethical leadership through the giving voice to values curriculum. New directions for student leadership, 2015(146), 35-47. Lehoux, P., Daudelin, G., Hivon, M., Miller, F. A., Denis, J. L. (2014). How do values shape technology design? An exploration of what makes the pursuit of health and wealth legitimate in academic spinà ¢Ã¢â€š ¬Ã‚ offs. Sociology of health illness, 36(5), 738-755.